Checks heart pumping function in people taking lurasidone
Studies whether lurasidone may affect heart pumping in adults with schizophrenia or bipolar disorder.
Key facts
- Who runs it
- Aydin Adnan Menderes University
- Where
- Aydin, TürkiyeSee the site
- Trial code
- Registry title
- Effects of Lurasidone on Left Ventricle Systolic Functions
- Status
- Not yet recruiting
- People taking part
- 62 people, planned
- Started
- Nov 2024
- Planned end
- 1 Jun 2025
- Type of study
- Observational
- Treatments tested
- Global Longitudinal Strain
- Record updated
- 19 November 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18 to 65 with schizophrenia or bipolar disorder who are going to start lurasidone. It checks whether lurasidone affects heart function.
- Age
- 18 to 65 years
- Sex
- All sexes can join.
- Disease stage
- Schizophrenia or bipolar disorder, diagnosed by the psychiatry clinic of the trial center.
- Earlier treatment
- Lurasidone must be indicated for the person. No earlier treatment is named.
Main reasons for not taking part
- Coronary artery disease
- Any kind of heart failure
- Severe valvular disease (heart valve disease)
- Not agreeing to take part in the trial
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Aged 18 to 65 years
- Diagnosed with schizophrenia or bipolar disorder by the psychiatry clinic of our center and indicated to use lurasidone molecule
- Hasn't been diagnosed with coronary artery disease, any kind of heart failure or severe valvular disease
Who cannot take part
- Patients who do not agree to participate to the trial
- Patient who do not meet the inclusion criteria
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Where in Türkiye
- Adnan Menderes UniversityAydin, TürkiyeContact: Sevil GulastiNo longer taking part
About the trial
What the trial wants to find out
The goal of our study to learn if lurasidone molecule which is used on patients with schizophrenia or bipolar disorder has any cardiotoxic effect.
The group in the trial
- Patients on Lurasidone
Patient who are admitted by the psychiatry clinic of our center and meet the inclusion criteria
Treatment: Global Longitudinal Strain
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Evaluation of Left Ventricle Systolic Functions of Patients On Lurasidone
- Plain-language title
- Checks heart pumping function in people taking lurasidoneGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06695676, who can take part
- Record updated
- 19 November 2024